Rapidly changing myeloma epidemiology in the general population: Increased incidence, older patients, and longer survival.

Autor: Turesson, Ingemar¹ Ingemar.turesson@med.lu.se, Bjorkholm, Magnus², Hveding Blimark, Cecilie^3,4, Kristinsson, Sigurdur⁵, Velez, Ramon⁶, Landgren, Ola⁷

Publikováno v: European Journal of Haematology. Aug2018, Vol. 101 Issue 2, p237-244. 8p.

A Prospective, Randomized Study Comparing Cefepime and Imipenem-Cilastatin in the Empirical Treatment of Febrile Neutropenia in Patients Treated for Haematological Malignancies.

Autor: Cherif, Honar¹ honar.cherif@kus.se, Bjorkholm, Magnus¹, Engervall, Per¹, Johansson, Peter², Ljungman, Per³, Hast, Robert¹, Kalin, Mats⁴

Publikováno v: Scandinavian Journal of Infectious Diseases. Aug2004, Vol. 36 Issue 8, p593-600. 8p.

Mo1035 - Iron-Deficiency Anemia and Prevalence of Celiac Disease - A Systematic Review with Meta-Analysis

Autor: Mahadev, Srihari, Lazkowska, Monika, Sundström, Johan, Bjorkholm, Magnus, Lebwohl, Benjamin, Green, Peter H., Ludvigsson, Jonas F.

Publikováno v: In Gastroenterology May 2018 154(6) Supplement 1:S

CHOEP-14 x 6 Followed by Systemic CNS Prophylaxis Cell Lymphoma (DLBCL)/Follicular Lymphoma (FL) Grade 3 with Age Adjusted IPI Score 2-3: Preliminary Results of a Nordic Lymphoma Group (NLG) Phase 2 Study Including 160 Patients Aged 18- 64 Years

Autor: Holte, Harald, Leppa, Sirpa M., Bjorkholm, Magnus, Fluge, Oystein, Jyrkkio, Sirkku, Delabie, Jan, Sundstrom, Christer, Karjalainen-Lindsberg, Marja-Liisa, Erlanson, Martin, Kolstad, Arne, Fossa, Alexander, Östenstad, Björn, Lofvenberg, Eva, Nordström, Maria, Pedersen, Lars Møller, Anderson, Harald, Jerkeman, Mats, Eriksson, Mikael

Publikováno v: Holte, H, Leppa, S M, Bjorkholm, M, Fluge, O, Jyrkkio, S, Delabie, J, Sundstrom, C, Karjalainen-Lindsberg, M-L, Erlanson, M, Kolstad, A, Fossa, A, Östenstad, B, Lofvenberg, E, Nordström, M, Pedersen, L M, Anderson, H, Jerkeman, M & Eriksson, M 2008, ' CHOEP-14 x 6 Followed by Systemic CNS Prophylaxis Cell Lymphoma (DLBCL)/Follicular Lymphoma (FL) Grade 3 with Age Adjusted IPI Score 2-3: Preliminary Results of a Nordic Lymphoma Group (NLG) Phase 2 Study Including 160 Patients Aged 18-64 Years ', Blood, no. 3604 . < http://abstracts.hematologylibrary.org/cgi/content/abstract/112/11/3604?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&fulltext=fluge&searchid=1&FIRSTINDEX=0&volume=112&issue=11&resourcetype=HWCIT >

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3062::d8de256c7e6887b9c34f933bc1264ae9
http://abstracts.hematologylibrary.org/cgi/content/abstract/112/11/3604?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&fulltext=fluge&searchid=1&FIRSTINDEX=0&volume=112&issue=11&resourcetype=HWCIT

Improved Survival in AL Amyloidosis: A Population-Based Study on 1,430 Patients Diagnosed in Sweden 1995-2013

Autor: Weiss, Brendan M., Lund, Sigrun H ^*, Bjorkholm, Magnus, Cohen, Adam D., Dember, Laura ^*, Landgren, Ola, Kristinsson, Sigurdur Y

Publikováno v: In Blood 2 December 2016 128(22):4448-4448